Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis

Published:2012-04-06 Issue:8 Volume:55 Page:3739-3755
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Debnath Joy¹,Siricilla Shajila¹,Wan Bajoie²,Crick Dean C.³,Lenaerts Anne J.³,Franzblau Scott G.²,Kurosu Michio¹

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee, 881 Madison, Memphis, Tennessee 38163, United States

2. Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States

3. Department of Microbiology, Immunology and Pathology, Colorado State University, 200 West Lake Street, Fort Collins, Colorado 80523, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm201608g

Reference45 articles.

1. Antibacterial Resistance, Wayampis Amerindians, French Guyana

2. New TB Drug Promises Shorter, Simpler Treatment

3. TB--A New Target, a New Drug

4. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating computational and experimental approaches in discovery and validation of MmpL3 pore domain inhibitors for specific labelling of Mycobacterium tuberculosis;International Journal of Biological Macromolecules;2024-11

2. Unraveling bacterial stress responses: implications for next-generation antimicrobial solutions;World Journal of Microbiology and Biotechnology;2024-07-29

3. In silico analysis and characterization of potential inhibitors of MmaA3, a methoxy mycolic acid synthase from Mycobacterium tuberculosis;Journal of Biomolecular Structure and Dynamics;2024-05-10

4. Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans;ACS Infectious Diseases;2024-01-31

5. In Vitro and In Vivo Antimicrobial Activity of an Oxidative Stress-Mediated Bicyclic Menaquinone Biosynthesis Inhibitor against MRSA;ACS Infectious Diseases;2023-09-01